Cti Biopharma Corp buy Needham & Company LLC
Start price
06.03.23
/
50%
€4.56
Target price
06.03.24
€8.42
Performance (%)
83.36%
End price
07.03.24
-
Summary
This prediction is currently being closed. With a performance of 83.36% the BUY prediction by Needham___Company_LL is a big success. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Cti Biopharma Corp | - | - | - |
iShares Core DAX® | -0.543% | 1.491% | 13.638% |
iShares Nasdaq 100 | -2.696% | -1.235% | 31.879% |
iShares Nikkei 225® | -2.863% | 2.491% | 12.078% |
iShares S&P 500 | -1.105% | 0.013% | 26.888% |
Comments by Needham___Company_LL for this prediction
In the thread Cti Biopharma Corp diskutieren
CTI BioPharma Corp. (NASDAQ: CTIC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $9.00 price target on the stock.
Ratings data for CTIC provided by MarketBeat
In the thread Trading Cti Biopharma Corp
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten